Symposium 8

  

February 2, 2017 (Thursday)


9:30 hrs


Welcome Address

Shri. Pankaj R. Patel
Chief Patron
The Ramanbhai Foundation
8th International Symposium

09.40 hrs

Lighting of the lamp

09.45 hrs


Opening remarks by Guest of Honour

Dr. Richard DiMarchi
Standiford H. Cox Distinguished Professor of Chemistry,
Linda & Jack Gill Chair in Biomolecular Sciences, Indiana University


09.55 hrs


Introduction to the keynote speaker

Dr. Sharvil P. Patel
Deputy Managing Director
Zydus Cadila

10.00 hrs Jeff Flier


“ The Problem of Reproducibility in Biomedical Research”

Jeff Flier, M.D.
Dean of the Faculty of Medicine,
Harvard Medical School, Harvard University

10.45 Q & A session


11.00 hrs


Vote of Thanks

Mr. Ganesh Nayak
COO & Executive Director
Zydus Cadila


11.30


Poster and Exhibition Session Inauguration

Dr. Sharvil P. Patel
Deputy Managing Director
Zydus Cadila

12:30 hrs

Lunch

Session I : Gastrointestinal and Liver Diseases

Chairpersons:

    • Charles F. Burant, MD, Ph.D., Professor of Metabolism, The Burant Lab,vUniversity of Michigan Medical School
    • Dr. S.K.Sarin, MD, DM, Senior Professor and Head, Hepatology, Director, Institute of Liver and Biliary Sciences (ILBS), &vWHO CC on Viral Hepatitis and Liver Diseases, New Delhi
    • Dr Ajay Duseja,  Department of Hepatology, PGIMER, Chandigarh

14:00 hrs

Jay Horton

“Molecular Mediators of NAFLD”

Jay Horton, MD
Distinguished Chair in Human Nutrition,
The University of Texas Southwestern
Medical Center

The University of Texas Southwestern
Medical Center

14:30 hrs

Asit Parikh

“Specificity Matters –Musings on (somewhat unconventional) development of a targeted immunomodulatory biologic”

Asit Parikh, MD, Ph.D
Head of GI Therapeutic Area Unit,
Takeda Pharmaceuticals

Takeda Pharmaceuticals

15:00 hrs

"NASH in India: Perspectives and Prospects for management"

Dr. S.K.Sarin, MD, DM
Senior Professor and Head, Hepatology,
Director, Institute of Liver and Biliary Sciences (ILBS), &
WHO CC on Viral Hepatitis and Liver Diseases, New Delhi

15:30 hrs

Tea-Break

16:00 hrs

“Non-alcoholic steatohepatitis modulation by novel FXR & PPAR agonists”

Bart Staels, Ph.D.
Director UMR INSERM 1011,
Professor at the Faculty of Pharmacy,

Université Lille 2, France

16:30 hrs

Walter Wahli

“Hepatocyte PPARα is protective against NAFLD in neonate and adult mice"

Walter Wahli, Ph.D
Professor of Metabolic Disease,
Lee Kong Chian School of Medicine,

Nanyang Technological University, Singapore

17:00 hrs

“Translating scientific discovery into a cure for NASH”

Arun Sanyal, MD
Professor of Medicine, Physiology and Molecular Pathology
Virginia Commonwealth University

Virginia Commonwealth University

17:30 hrs

Wrap-up

 

February 3, 2017 (Friday)

Session II : Cancer Therapeutics

09:15 hrs   

Introduction

Chairpersons:

  • Kapil Dhingra, MD; Retired Vice President, Roche, Director, KAPital Consulting LLC
  • Phil Dawson, Ph.D., Associate Dean of Graduate Studies, Department of Chemistry California, Campus, The Scripps Research Institute

09.30 hrs

Kapil Dhingra

“Enabling personalized medicine in oncology: Current status and perspectives on the future”

Kapil Dhingra, MD
Retired Vice President, Roche,
Director, KAPital Consulting LLC

10:00 hrs Martin Pule

“T-cell engineering for Cancer Application”

Martin Pule, M.D.
Founder & Chief Scientific Officer
Autolus Limited

10:30 hrs

“ZYTP1 -  a novel PARP inhibitor for management of solid tumors”


Mukul Jain, Ph. D.
Senior V P, Pharmacology & Toxicology
Zydus Research Center

11:00 hrs

Tea-Break

11:30 hrs

Lewis T. Williams

“Discovery of New Protein Drug Targets by Comprehensively Screening the Extracellular Proteome”

Lewis T. "Rusty" Williams, M.D., Ph.D.
Founder, President and CEO,
Five Prime Therapeutics, Inc.

12:00 hrs

Karen Reue

“Mouse Models for Pharmacogenomic Discovery”

Karen Reue, Ph.D.
Professor, Human Genetics, Department of Human
Genetics, David Geffen School of Medicine,
University of California, Los Angeles

12:30 hrs

Lunch & Poster Sessions

Session III : Anti-infectives & Public Health

Chairpersons:

  • Bikash Medhi, MBBS,MD(AIIMS),MAMS,FIMSA Professor, Department of Pharmacology, PGIMER, Chandigarh
  • Reinhard Glueck, Ph.D; Chief Scientific Officer Zydus-VTC

14:00 hrs

“Public-Private Partnerships to Accelerate Innovation in Product Development”

Rajeev Venkayya, MD
President of Global Vaccine Business Unit,
Takeda Pharmaceuticals

14:30 hrs

Jorg Mohrle

“Developing next-generation malaria medicines to address drug resistance and increase the operational feasibility of malaria elimination efforts”

Jörg Möhrle, Ph.D.
Vice President, Head of Translational Medicine, Research & Development, Medicines for Malaria Venture

15:00 hrs

Tea-Break           

15:30 hrs

“The Discovery and Development of New Antivirals”

Manoj Desai, Ph.D.
Vice President, Medicinal Chemistry
Gilead Sciences

16:00 hrs

“Opportunities and Challenges in the Vaccine Industry"

Rahul Singhvi, Sc.D.
Chief Operating Officer,
Takeda Vaccines

16:30 hrs

Panel Discussion
“Is there more integration between cancer, viral disease and the microbiome?”

  • Jeff Flier, M.D., HMS Dean (2007-16), Harvard Medical School,
  • Richard DiMarchi, Ph.D., Standiford H. Cox Distinguished Professor of Chemistry, Linda & Jack Gill Chair in Biomolecular Sciences, Indiana University
  • Rajeev Venkayya, MD, President of Global Vaccine Business Unit, Takeda Pharmaceuticals
  • Kapil Dhingra, MD, Retired Vice President, Roche, Director, KAPital Consulting LLC
  • Manoj Desai, Ph.D., Vice President, Medicinal Chemistry, Gilead Sciences
  • Arun Sanyal, MD, Professor of Medicine, Physiology and Molecular Pathology, Virginia Commonwealth University

17:30 hrs

Wrap-up

 

February 4, 2017 (Saturday)

Session IV : Cardio-metabolic Diseases

09.15 hrs

Introduction

Chairpersons:

  • Jeff Flier, M.D.; Dean of the Faculty of Medicine, Harvard Medical School, Harvard University
  • Jay Horton, MD Distinguished Chair in Human Nutrition, The University of Texas Southwestern Medical Center

09.30 hrs

Terry Flier

“FGF21:physiology and therapeutic potential”

Terry Flier, MD

Professor of Medicine, Harvard Medical School
Division of Endocrinology,
Beth Israel Deaconess Medical Center

10:00 hrs

Terry Flier

“Evolving mechanisms and continued challenges of the FGF-21 pathway as a therapeutic target”

Saswata Talukdar, Ph.D.
Director and Leader of CardioMetabolic Disease,
Early Discovery group,
Merck Research Laboratories

10:30 hrs

Charles F. Burant

“Metabolism and metabolic aging”

Charles F. Burant, MD, Ph.D.
Professor of Metabolism, The Burant Lab,
University of Michigan Medical School

11:00 hrs

“Melanocortins: From Pharmacology to Pharmacotherapy”

Roger Cone, Ph.D.
Mary Sue Coleman Director, Life Sciences Institute
Professor of Molecular and Integrative Physiology
University of Michigan

11:30 hrs

Lunch & Poster

Session V : Chemical Biotechnology

Chairpersons:

  • Lewis T. "Rusty" Williams, M.D., Ph.D., Founder, President and CEO, Five Prime Therapeutics, Inc.
  • Manoj Desai, Ph.D., Vice President, Medicinal Chemistry, Gilead Sciences

14:00 hrs

David Craik

“Plants as bio-factories for producing peptide-based pharmaceuticals”

David Craik, Ph.D.
Group Leader, Chemistry and Structural
Biology Division, The University of Queensland

14:30 hrs

Phil Dawson

“Making connections in peptide chemistry”

Phil Dawson, Ph.D.
Associate Dean of Graduate Studies,
Department of Chemistry California
Campus, The Scripps Research Institute

15:00 hrs

High productive cell-lines, ADC process development and challenges”

Palani Palaniappan, Ph.D.
Vice President & Head,
Biologics & New Modalities Development,

Takeda Pharmaceuticals

15:30 hrs

Richard DiMarchi

“Chemical Biotechnology Applied to Metabolic Diseases”

Richard DiMarchi, Ph.D.
Standiford H. Cox Distinguished Professor of Chemistry,
Linda & Jack Gill Chair in Biomolecular Sciences,
Indiana University

16:00 hrs

Best Poster Awards

  • Oral Poster Presentation 1 (10 min)
  • Oral Poster Presentation 2 (10 min)
  • Oral Poster Presentation 3 (10 min)

16:30 hrs

Closing Comments

Dr. Sharvil P. Patel
Deputy Managing Director
Zydus Cadila

 

 

 

 

Home Contact Us Life-sciences Exhibition